FDA Fees On Industry Haven't Fixed Delays In Generic Drug Approvals
Four years after user fees were imposed on to speed up the review of generic drug applications by the Food and Drug Administration, more than 4,000 generics remain in limbo.
leia mais em NPR
No comments:
Post a Comment